Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

This study has been completed.
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by:
The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT00804622
First received: December 8, 2008
Last updated: July 10, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)